ac
gubbel
baak
g
nielsen
lp
riedel
c
arpi
respiratori
virolog
microbiolog
intens
care
unit
prospect
cohort
studi
apmi
aim
determin
frequenc
common
respiratori
virus
patient
admit
intens
care
unit
respiratori
symptom
evalu
clinic
characterist
compar
result
routin
microbiolog
diagnost
throat
swab
intens
carepati
year
acut
respiratori
symptom
collect
upon
admiss
analys
multiplex
realtim
polymeras
chain
reaction
commun
respiratori
virus
blood
respiratori
tract
specimen
analys
bacteria
fungi
upon
clinician
request
clinic
paraclin
data
collect
virus
detect
studi
patient
five
virusposit
patient
possibl
clinic
relev
bacteria
fungi
codetect
patient
exacerb
copd
associ
viral
infect
p
comorbid
clinic
paraclin
paramet
death
independ
viral
infect
codetect
bacteriafungi
conclus
respiratori
virus
frequent
detect
patient
investig
clinic
paraclin
paramet
differ
viral
infect
compar
agent
thu
respiratori
virus
like
similar
impact
clinic
cours
agent
virusposit
patient
polymicrobi
aetiolog
identifi
comprehens
sensit
diagnost
method
emphas
enhanc
respiratori
diagnost
commun
respiratori
virus
frequent
caus
acut
respiratori
tract
infect
communityacquir
pneumonia
respiratori
virus
may
also
trigger
acut
exacerb
preexist
chronic
condit
asthma
chronic
obstruct
pulmonari
diseas
copd
congest
heart
failur
patient
need
hospit
even
intens
care
treatment
still
respiratori
virus
gener
consid
clinic
relev
monitor
critic
ill
patient
today
larg
number
pathogen
mainli
virus
identifi
rapid
highli
sensit
specif
molecular
method
polymeras
chain
reaction
pcr
clinic
difficult
determin
microbiolog
aetiolog
respiratori
tract
infect
microbiolog
find
often
influenc
antibiot
treatment
admiss
intens
care
unit
icu
make
microbiolog
test
result
difficult
interpret
may
disguis
signific
pathogen
furthermor
differenti
pathogen
caus
invas
infect
colon
often
imposs
implic
patient
infect
differ
pathogen
differ
prognosi
respons
treatment
viral
diagnost
often
use
secondlin
diagnost
save
case
signific
bacteri
pathogen
reveal
initi
analys
case
deterior
clinic
symptom
despit
treatment
reveal
bacteria
approach
lead
delay
potenti
benefici
antivir
treatment
aetiolog
sever
acut
respiratori
diseas
remain
undetermin
patient
virolog
molecular
method
improv
markedli
recent
year
introduct
molecular
techniqu
howev
still
studi
use
method
detect
larg
number
virus
icupati
purpos
studi
determin
frequenc
respiratori
virus
adult
icupati
without
select
predispos
condit
describ
clinic
characterist
epidemiolog
compar
result
current
practic
respiratori
diagnost
patient
studi
one
includ
comprehens
virolog
pcranalys
convent
microbiolog
analys
mimick
clinic
everyday
realiti
icu
adult
patient
year
age
admit
success
clinic
suspicion
acut
respiratori
infect
intens
care
unit
two
univers
hospit
copenhagen
denmark
test
presenc
respiratori
virus
throat
swab
one
icu
bed
icua
collect
swab
decemb
novemb
six
bed
icub
collect
swab
januari
august
throat
swab
taken
upon
admiss
includ
addit
virolog
analys
request
sampl
materi
sent
bacteri
diagnost
throat
swab
chosen
studi
due
noninvas
natur
sampl
collect
combin
minim
discomfort
patient
accept
sensit
inclus
patient
base
upon
assess
attend
physician
inclus
criteria
wide
respiratori
virus
alway
appear
uniform
clinic
pictur
patient
includ
sign
respiratori
distress
failur
appar
includ
exacerb
copd
asthma
pneumonia
patient
fever
accompani
uncompens
congest
heart
failur
multipl
organ
dysfunct
syndrom
metabol
acidosi
sepsi
cardiac
arrest
also
includ
throat
swab
analys
consecut
presenc
respiratori
virus
upon
arriv
depart
virolog
staten
serum
institut
copenhagen
denmark
analys
includ
influenza
b
respiratori
syncyti
viru
rsv
human
metapneumoviru
hmpv
parainfluenza
viru
coronavirus
cov
cov
cov
rhinoviru
adenoviru
use
modifi
version
multiplex
realtim
pcrassay
publish
previous
brittainlong
et
al
also
includ
analys
enteroviru
chlamydophila
pneumonia
mycoplasma
pneumonia
technic
purpos
omit
assay
amplif
perform
stratagen
thermocycl
mxpro
softwar
stratagen
la
jolla
california
usa
follow
manufactur
instruct
subtyp
influenza
base
inhous
accredit
pcrassay
detect
haemagglutininand
neuraminidaseregion
bacteri
fungal
analys
perform
depart
clinic
microbiolog
herlev
hospit
herlev
denmark
serv
hospit
analys
consist
cultur
identif
antibiot
suscept
test
pcr
legionella
pneumophila
chlamophila
pneumonia
mycoplasma
pneumonia
perform
upon
request
clinician
materi
includ
blood
tracheal
aspir
bronchoalveolar
lavag
sputum
pleural
fluid
sampl
collect
within
day
viral
sampl
date
includ
evalu
bacteri
fungal
content
sampl
done
accord
normal
procedur
depart
clinic
microbiolog
gramstain
respiratori
secret
evalu
technician
microbiologist
secret
contain
epithelium
deeper
part
airway
microscop
evalu
consid
suffici
materi
bacteria
associ
epithelium
consid
possibl
pathogen
cultur
bacteria
done
distinguish
usual
nonpathogen
possibl
pathogen
organ
blood
cultur
perform
accord
well
recogn
method
clinic
inform
regard
hospit
epidemiolog
comorbid
record
medic
record
inform
includ
follow
age
gender
underli
comorbid
use
immunosuppress
drug
respiratori
symptom
diagnos
admiss
diagnos
discharg
length
hospit
stay
icu
stay
intub
simplifi
acut
physiolog
score
ii
sap
ii
score
administr
antibiot
noninvas
ventil
chest
xray
laboratori
analys
result
physic
examin
includ
temperatur
satur
stethoscop
find
clinic
sign
respiratori
infect
distress
sap
iiscor
sever
diseas
classif
system
appli
first
h
admiss
icu
result
point
score
interv
predict
mortal
patient
icua
routin
score
accord
sap
iiguidelin
admiss
establish
routin
icub
studi
period
case
patient
score
retrospect
accord
intern
sap
iiguidelin
one
anaesthesiologist
blind
regard
result
studi
immunosuppress
defin
either
malign
diseas
administr
chemotherapi
radiotherapi
within
one
year
admiss
use
corticosteroid
dose
exceed
equival
mgday
prednisolon
least
month
mgkgday
least
week
last
month
admiss
intergroup
characterist
compar
use
wilcoxon
rank
sum
test
numer
variabl
chisquar
test
fisher
exact
test
dichotom
variabl
continu
variabl
median
interquartil
rang
iqr
estim
multipl
group
numer
variabl
compar
use
kruskalw
test
multipl
group
dichotom
variabl
compar
use
chisquar
test
fisher
exact
test
appropri
pvalu
consid
signific
epidata
version
epidata
associ
denmark
use
data
entri
statist
analys
perform
use
stataic
version
statacorp
lp
usa
nation
board
health
denmark
danish
data
protect
agenc
approv
data
collect
ref
accord
danish
law
given
observ
natur
studi
without
deviat
current
medic
practic
approv
necessari
inform
consent
waiv
total
throat
swab
collect
icua
throat
swab
collect
icub
fig
five
patient
incorrectli
regist
laboratori
six
medic
record
unavail
patient
retrospect
found
meet
inclus
criteria
assess
admiss
patient
exclud
final
studi
group
consist
patient
suspect
respiratori
infect
upon
admiss
icua
n
icub
n
geograph
locat
patient
popul
medic
care
two
unit
compar
median
age
final
studi
group
year
iqr
year
men
total
patient
viru
detect
fig
clinic
paraclin
characterist
shown
tabl
frequenc
patient
admit
hospit
exacerb
chronic
obstruct
pulmonari
diseas
copd
higher
virusposit
group
five
patient
vs
eight
patient
x
test
p
pneumonia
frequent
reason
admiss
group
among
virusposit
pneumonia
occur
nine
influenzapati
also
observ
patient
hmpv
rsv
adenoviru
plasma
concentr
creactiv
protein
crp
independ
viral
infect
larg
interquartil
rang
also
detect
virusposit
patient
clinic
intervent
diagnos
upon
discharg
present
tabl
virusposit
patient
receiv
antibiot
compar
virusneg
patient
twelv
virusposit
patient
receiv
combin
antibiot
therapi
also
case
virusneg
patient
x
test
p
oseltamivir
administ
three
virusposit
patient
period
pandem
addit
clinic
paramet
comorbid
intervent
discharg
diagnos
differ
significantli
patient
group
virusposit
group
patient
transfer
icu
day
less
hospit
admitt
virusneg
group
case
patient
virus
patient
includ
studi
group
posit
viru
frequent
detect
influenza
n
rsv
n
fig
regard
influenza
subtyp
four
patient
three
remain
two
patient
posit
influenza
season
subtyp
could
determin
bacteria
fungi
neg
viral
swab
found
patient
fig
patient
bacteria
fungi
respiratori
specimen
n
blood
n
n
within
day
viral
sampl
collect
date
overal
isol
frequent
detect
respiratori
specimen
candida
albican
n
fig
frequent
detect
isol
blood
coagulaseneg
staphylococci
con
n
patient
posit
cultur
cultur
result
consid
clinic
signific
respiratori
diseas
patient
posit
respiratori
cultur
bacteria
consid
clinic
relev
isol
respiratori
specimen
patient
isol
includ
streptococcu
pneumonia
n
staphylococcu
aureu
n
pseudomona
aeruginosa
n
haemophilu
influenza
n
klebsiella
pneumonia
n
legionella
pneumophila
n
virusneg
patient
posit
blood
cultur
bacteria
like
clinic
relev
respiratori
diseas
isol
seven
patient
isol
includ
pneumonia
n
aureu
n
p
aeruginosa
n
remain
virusneg
patient
without
posit
microbiolog
tracheal
aspir
perform
eight
patient
sputum
three
bronchoalveolar
lavag
one
blood
cultur
patient
two
patient
respiratori
blood
cultur
collect
codetect
microbiolog
agent
abovement
virusposit
patient
total
patient
found
coinfect
colon
bacteria
fungi
five
cultur
result
consid
clinic
relev
respiratori
symptom
tabl
five
coinfect
detect
tracheal
aspir
repres
total
studi
popul
addit
one
patient
hmpv
con
candida
dubliniensi
unknown
clinic
signific
isol
blood
cultur
nearli
half
patient
codetect
microb
includ
clinic
signific
agent
admit
directli
icu
one
patient
admit
day
hospit
admiss
preval
viru
patient
coinfect
colon
influenza
two
three
virus
influenza
b
cov
cov
hmpv
rhinoviru
detect
frequent
microbiolog
isol
tracheal
aspir
consid
possibl
clinic
signific
aureu
n
p
aeruginosa
k
pneumonia
detect
fig
distribut
virus
frequent
isol
microorgan
studi
popul
influenza
subtyp
includ
untyp
strain
coagulaseneg
staphylococci
catharrhali
marcescen
e
cloaca
k
oxytoca
p
vulgari
p
acn
pseudomonasspeci
micrococcusspeci
bacillusspeci
c
dubliniensi
c
koseri
c
glabrata
c
tropicali
c
krusei
unspecifi
candidaspeci
total
patient
test
virus
includ
parainfluenza
virus
nineteen
virusposit
coinfect
clinic
signific
microbiolog
pathogen
found
four
virusposit
patient
virusneg
patient
posit
either
bacteria
fungi
two
patient
test
thirtyfour
neg
bacteriafungi
agent
consid
relev
respiratori
symptom
isol
patient
seven
blood
tracheal
aspir
tabl
summar
clinic
paramet
four
group
patient
detect
without
virus
without
bacteriafungi
identifi
blood
respiratori
specimen
within
five
day
viral
sampl
date
chronic
obstruct
pulmonari
diseas
copd
frequent
predispos
comorbid
group
patient
virusonli
infect
compar
patient
copdpati
also
frequent
observ
virusonli
infect
admit
exacerb
sapsii
score
independ
microbiolog
agent
detect
biochem
radiolog
result
could
reliabl
differ
group
howev
appear
virusonli
patient
lower
median
level
creactiv
protein
comparison
bacteriafungionli
patient
mgl
compar
mgl
wilcoxon
rank
sum
p
separ
group
two
group
also
differ
regard
median
durat
mechan
ventil
appear
shorter
among
patient
virusonli
infect
day
compar
day
bacteria
fungionli
patient
wilcoxon
rank
sum
p
group
posit
microbiolog
high
frequenc
develop
pneumonia
also
patient
virusonli
infect
patient
includ
studi
die
within
day
viral
sampl
date
nonsurvivor
median
age
year
iqr
year
higher
survivor
median
age
year
iqr
year
wilcoxon
rank
sum
p
immunosuppress
seen
nonsurvivor
nine
survivor
x
test
p
median
sap
iiscor
nonsurvivor
iqr
higher
survivor
score
iqr
wilcoxon
rank
sum
p
virusposit
patient
die
four
patient
detect
influenza
two
patient
detect
rsv
remain
five
posit
test
adenoviru
rhinoviru
hmpv
cov
cov
total
four
nine
influenza
aposit
patient
studi
popul
two
pandem
strain
two
three
rsvposit
patient
die
virusposit
nonsurvivor
five
codetect
bacteriafungi
respiratori
specimen
two
patient
detect
influenza
c
albican
one
rhinoviru
c
albican
one
cov
aureu
one
cov
e
coli
c
albican
signific
differ
virusposit
survivor
nonsurvivor
demograph
clinic
characterist
predict
fatal
outcom
abovement
virusneg
patient
posit
respiratori
blood
cultur
bacteria
fungi
die
frequent
isol
c
albican
n
enterococci
n
aureu
n
pneumonia
n
p
aeruginosa
n
k
pneumonia
n
h
influenza
n
fatal
outcom
independ
infect
differ
microbiolog
agent
studi
knowledg
one
studi
compar
comprehens
virolog
pcr
method
microbiolog
find
adult
icupati
without
select
predispos
condit
studi
mimic
clinic
everyday
realiti
icu
attempt
eas
comparison
result
studi
clinic
practic
virolog
analys
base
multiplex
realtim
pcrmethod
detect
larg
number
respiratori
virus
gradual
replac
previou
less
sensit
method
rapid
diagnost
virus
icupati
heterogen
group
often
sever
concurr
diseas
complex
medic
histori
although
major
guidelin
manag
communityacquir
pneumonia
consensu
regard
microbiolog
diagnost
approach
still
lack
instanc
differ
copd
chronic
obstruct
respiratori
diseas
icu
intens
care
unit
sap
ii
simplifi
acut
physiolog
score
ii
crp
creactiv
protein
cardiac
diseas
includ
congest
heart
failur
former
myocardi
infarct
angina
pectori
arteri
hypertens
differ
signific
compar
two
group
p
differ
signific
compar
two
group
p
numer
data
present
median
interquartil
rang
categor
data
frequenc
percentag
approach
opinion
sampl
materi
suitabl
identif
respiratori
agent
also
proper
sampl
collect
verifi
previous
administ
antibiot
may
influenc
result
markedli
eventu
disguis
pathogen
promot
select
microorgan
present
patient
presenc
bacteria
fungi
sampl
airway
icuset
rare
consid
diagnost
given
infect
isol
could
repres
infect
colon
organ
even
blood
cultur
microorgan
detect
may
necessarili
repres
infect
result
studi
illustr
issu
respiratori
isol
isol
detect
blood
cultur
virusneg
patient
consid
clinic
relev
respiratori
diseas
previous
estim
frequenc
respiratori
virus
icupati
vari
detect
rate
virus
studi
popul
confirm
togeth
studi
respiratori
virus
common
icupati
confirm
valid
pcr
method
use
influenza
viru
frequent
detect
follow
rsv
support
previou
result
detect
respiratori
virus
influenza
parainfluenza
virus
coronavirus
presenc
acut
respiratori
symptom
previous
shown
caus
sever
pneumonia
requir
intens
care
treatment
mechan
ventil
respiratori
virus
detect
studi
rhinovirus
rsv
hmpv
also
shown
sever
studi
caus
signific
symptom
morbid
potenti
need
intens
care
treatment
respiratori
virus
detect
multiplex
pcr
present
show
season
variat
frequenc
although
week
miss
begin
influenza
season
studi
main
season
differ
virus
cover
season
variat
virus
studi
period
accommod
time
sampl
collect
could
interf
number
posit
sampl
perform
late
clinic
cours
infect
sampl
taken
within
day
admiss
acut
respiratori
diseas
regard
clinic
impact
respiratori
virus
detect
found
paramet
reliabl
could
distinguish
virusposit
virusneg
patient
differ
result
clinic
paraclin
analys
underlin
import
comprehens
sensit
diagnost
measur
accur
diagnos
sought
clinic
judgment
alon
distinguish
differ
aetiolog
clinic
intervent
outcom
virusposit
virusneg
patient
also
similar
group
even
consid
codetect
microbiolog
agent
except
slightli
shorter
ventil
time
patient
virusonli
infect
result
may
suggest
respiratori
virus
similar
influenc
clinic
cours
bacteria
fungi
diagnos
upon
discharg
show
larg
amount
patient
develop
pneumonia
among
virusposit
virusneg
patient
although
virusposit
patient
treat
antibiot
third
influenzaposit
patient
pneumonia
receiv
oseltamivir
case
occur
pandem
focu
influenza
high
coincid
detect
viru
one
respiratori
microbiolog
agent
constitut
viral
infect
studi
total
studi
popul
fit
well
result
similar
studi
sever
studi
throughout
last
centuri
demonstr
associ
respiratori
virus
bacteri
infect
frequent
combin
viru
bacteria
studi
influenza
aureu
welldescrib
relationship
patient
admit
either
directli
icu
less
day
hospit
admiss
make
nosocomi
infect
select
opportunist
agent
less
like
influenzaposit
patient
frequent
coincid
find
respiratori
cultur
two
third
microorgan
consid
clinic
signific
like
repres
sever
superinfect
recent
studi
report
similar
result
approxim
half
influenzapati
present
coinfect
find
demonstr
neither
bacteriolog
virolog
analys
stand
alon
studi
patient
viru
plu
microbiolog
agent
tend
admit
ventil
similar
period
virusneg
bacteriafungiposit
patient
could
indic
sever
morbid
caus
combin
agent
found
associ
number
death
differ
combin
microbiolog
agent
larg
frequenc
pneumonia
note
even
among
virusonli
infect
patient
find
line
recent
studi
partli
support
studi
nearli
icupati
found
strong
associ
infect
virus
bacteria
hospit
develop
septic
shock
multipl
organ
dysfunct
syndrom
oppos
result
studi
also
demonstr
strong
associ
mortal
patient
infect
inevit
import
influenc
clinic
cours
patient
admit
icu
howev
current
microbiolog
diagnost
practic
leav
mani
patient
undiagnos
interpret
bacteri
result
often
difficult
ad
comprehens
multiplex
realtim
pcr
increas
sensit
respiratori
diagnost
studi
result
microbiolog
agent
provid
patient
though
agent
like
clinic
interest
result
virusposit
patient
codetect
microorgan
equal
difficult
interpret
isol
clinic
interest
potenti
pathogen
effect
presum
colon
organ
remain
cultureposit
patient
rule
though
support
fact
interpret
current
practic
microbiolog
analys
difficult
icupati
also
recent
point
studi
investig
biomark
bronchoalveolar
lavag
diagnos
respiratori
viral
infect
clinic
pictur
respiratori
tract
infect
icu
complic
fact
sever
infect
focu
outsid
respiratori
system
may
also
result
pulmonari
congest
infiltr
due
ard
chang
may
resembl
pneumonia
pathogen
may
found
either
respiratori
secret
blood
improv
sensit
microbiolog
analys
molecular
method
ad
detect
method
biomark
analys
may
reduc
number
sever
ill
patient
undetermin
aetiolog
respiratori
diseas
virusneg
patient
receiv
combin
antibiot
therapi
significantli
frequent
might
connect
gener
wors
clinic
condit
noteworthi
virusposit
patient
receiv
antibiot
even
combin
therapi
may
cloud
interpret
bacteri
analys
contribut
lack
diagnos
patient
comprehens
diagnost
programm
today
practic
includ
wider
use
molecular
method
bacteriolog
could
possibl
result
accur
diagnos
reduct
use
empir
broadspectrum
antibiot
treatment
greater
perspect
could
contribut
reliev
increas
issu
antibiot
resist
still
need
great
awar
refin
clinic
guidelin
implement
comprehens
microbiolog
virolog
analys
address
issu
awar
limit
studi
main
low
number
virusposit
patient
lack
control
group
patient
without
respiratori
symptom
sapsiiscor
perform
retrospect
one
hospit
although
perform
blind
regard
result
may
influenc
score
patient
admit
either
directli
icu
transfer
less
day
hospit
admiss
still
antibiot
treatment
nosocomi
infect
select
opportunist
agent
may
happen
prior
enter
studi
unfortun
inform
regard
avail
suitabl
amount
patient
studi
death
independ
presenc
virus
fairli
larg
proport
virusposit
patient
develop
pneumonia
investig
clinic
paraclin
paramet
differ
viral
infect
compar
agent
may
suggest
respiratori
virus
similar
impact
clinic
cours
pathogen
interpret
microbiolog
result
icuset
difficult
sever
diseas
condit
may
combin
patient
result
might
influenc
previous
administ
antibiot
virusposit
patient
studi
respiratori
bacteria
fungi
consid
clinic
signific
identifi
demonstr
neither
virolog
bacteriolog
analys
stand
alon
patient
test
optim
sensit
comprehens
method
interpret
prefer
done
collabor
clinic
microbiologist
specialist
infecti
diseas
enhanc
diagnost
process
author
declar
compet
interest
natur
